Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Centenial Surgical Suture Ltd met on February 12, 2026, and approved the Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2025, under Regulation 33 of SEBI (LODR) Regulations, 2015. The meeting commenced at 6:30 p.m. and concluded at 6:50 p.m. The filing was signed by Mahima Bathwal, Company Secretary & Compliance Officer. The actual financial numbers are not included in this cover-letter filing and would have been attached separately.
This is a routine regulatory filing confirming the timely approval of Q3 FY26 results. Shareholders should look at the separately filed financial results for actual performance metrics. No material strategic or governance decisions were announced in this filing.